The Clinical Impact of Next-Generation Sequencing (NGS) on Pharmacy Practice
December 10th 2013Genomic sequencing is rapidly increasing its value as a clinical tool in the diagnosis and treatment of many diseases, including cancer. In his presentation, Justin M. Balko, PharmD, PhD, from Vanderbilt University, provided a background on the current state of next-generation genomic sequencing (NGS), and the potential role that pharmacists play as this science continues to evolve.
2 Commerce Drive
Cranbury, NJ 08512